Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity

Caveolin-1 在维持血视网膜屏障完整性中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The blood-retinal barrier (BRB) selectively and tightly regulates the local environment of the neural retina. Loss of BRB integrity is a common pathology in three major causes of blindness: diabetic retinopathy; age- related macular degeneration; and retinopathy of prematurity. Recent evidence indicates that caveolin-1 (Cav- 1), an integral protein component of specialized lipid micro-domains called caveolae, is essential for normal retinal function. Cav-1 null mice display reduced retinal function in Cav-1 null mice as indicated by electroretinography (ERG) that suggested at a photoreceptor defect. However, this reduced photoreceptor function could not be explained by a direct effect on phototransduction as responses were normal in recordings from isolated Cav-1 null rods. This suggests that the functional deficit in Cav-1 null retinas results from an abnormal local environment surrounding photoreceptors. In support of this hypothesis, compelling evidence indicates that Cav-1 null mice have a hyper-permeable BRB. The increased permeability correlates with alterations in tight junctions, changes in Na/K-ATPase activity, and outer retinal edema. Cav-1 null mice provide compelling data showing a clear loss of retinal pigment epithelial and vascular barrier functions. This increased permeability alters the normal photoreceptor environment which is consistent with reduced retinal function and age-related retinal degeneration observed in these mice. Furthermore, when subjected to a stress paradigm (oxygen-induced retinopathy), Cav-1 null mice display severe sub-retinal and intra-retinal hemorrhaging. These findings clearly indicate that Cav-1 expression/function is essential for the maintenance of a robust BRB but the mechanism(s) of this regulation is unknown. The first aim is designed to determine the role of Cav-1 in regulating barrier activity specifically within the retinal pigment epithelium using cell-specific, inducible genetic deletion. The second aim will test the role of Cav-1 in the structural organization of lipids and proteins in epithelial cell-cell contacts and apical process. The final aim will focus on the role that dysregulation of the Na/K-ATPase plays and how Cav-1 regulates ATPase activity. PUBLIC HEALTH RELEVANCE: Loss of blood-retinal barrier integrity is a common pathology in three major causes of blindness: diabetic retinopathy; age-related macular degeneration; and retinopathy of prematurity. This project is designed to study mechanisms that regulate blood-retinal barrier integrity to define novel potential therapeutic strategies to ameliorate pathological blood-retinal barrier permeability.
描述(申请人提供):血-视网膜屏障(BRB)选择性地和严格地调节神经视网膜的局部环境。BRB完整性的丧失是导致失明的三个主要原因的常见病理:糖尿病视网膜病变、老年性黄斑变性和早产儿视网膜病变。最近的证据表明,小窝蛋白-1(Cav-1)是一种被称为小窝的特殊脂质微域的不可或缺的蛋白质成分,对正常的视网膜功能是必不可少的。视网膜电波图(ERG)显示,Cav-1基因缺失的小鼠视网膜功能下降,提示存在光感受器缺陷。然而,这种光感受器功能的降低不能用对光传导的直接影响来解释,因为在分离的Cav-1空杆记录中,反应是正常的。这表明Cav-1缺失视网膜的功能缺陷是光感受器周围局部环境异常的结果。为了支持这一假设,令人信服的证据表明,Cav-1基因缺失的小鼠有一种高渗透性的BRB。通透性的增加与紧密连接的改变、Na/K-ATPase活性的改变和视网膜外部水肿有关。CAV-1基因缺失的小鼠提供了令人信服的数据,表明视网膜色素上皮和血管屏障功能明显丧失。这种增加的通透性改变了正常的光感受器环境,这与在这些小鼠中观察到的视网膜功能降低和年龄相关的视网膜退化是一致的。此外,当受到应激模式(氧诱导的视网膜病变)时,Cav-1基因缺失的小鼠表现出严重的视网膜下和视网膜内出血。这些发现清楚地表明,Cav-1的表达/功能对于维持强大的BRB是必不可少的,但这种调节的机制(S)尚不清楚。第一个目的是通过细胞特异性的、可诱导的基因缺失来确定Cav-1在调节视网膜色素上皮内的屏障活性中的作用。第二个目标将测试Cav-1在上皮细胞-细胞接触和心尖过程中脂质和蛋白质的结构组织中的作用。最终目标将集中在Na/K-ATPase失调所起的作用以及Cav-1如何调节ATPase活性。 公共卫生相关性:血-视网膜屏障完整性丧失是导致失明的三个主要原因的常见病理:糖尿病视网膜病变、老年性黄斑变性和早产儿视网膜病变。该项目旨在研究调节血-视网膜屏障完整性的机制,以确定新的潜在治疗策略,以改善病理性血-视网膜屏障的通透性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL H ELLIOTT其他文献

MICHAEL H ELLIOTT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL H ELLIOTT', 18)}}的其他基金

Caveolae-based mechanosensors for conventional outflow regulation
用于传统流出调节的基于小凹的机械传感器
  • 批准号:
    10186755
  • 财政年份:
    2018
  • 资助金额:
    $ 37.28万
  • 项目类别:
Caveolae-based mechanosensors for conventional outflow regulation
用于传统流出调节的基于小凹的机械传感器
  • 批准号:
    9596193
  • 财政年份:
    2018
  • 资助金额:
    $ 37.28万
  • 项目类别:
P30 Center Core Grant for Vision Research
P30 中心视觉研究核心资助
  • 批准号:
    10272006
  • 财政年份:
    2011
  • 资助金额:
    $ 37.28万
  • 项目类别:
P30 Center Core Grant for Vision Research
P30 中心视觉研究核心资助
  • 批准号:
    10696214
  • 财政年份:
    2011
  • 资助金额:
    $ 37.28万
  • 项目类别:
P30 Center Core Grant for Vision Research
P30 中心视觉研究核心资助
  • 批准号:
    10477424
  • 财政年份:
    2011
  • 资助金额:
    $ 37.28万
  • 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
  • 批准号:
    8963726
  • 财政年份:
    2009
  • 资助金额:
    $ 37.28万
  • 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
  • 批准号:
    10683155
  • 财政年份:
    2009
  • 资助金额:
    $ 37.28万
  • 项目类别:
Role of caveolin-1 in the maintenance of blood-retinal barrier integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
  • 批准号:
    9563983
  • 财政年份:
    2009
  • 资助金额:
    $ 37.28万
  • 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
  • 批准号:
    10475582
  • 财政年份:
    2009
  • 资助金额:
    $ 37.28万
  • 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
  • 批准号:
    8580554
  • 财政年份:
    2009
  • 资助金额:
    $ 37.28万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.28万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.28万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.28万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 37.28万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 37.28万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 37.28万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 37.28万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 37.28万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 37.28万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 37.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了